Population
Obese individuals and animal models of obesity
Design
Review
Authors
Loading...
Myocardial steatosis merits prospective study in obesity cardiomyopathy; leaves open its biomarker or therapeutic utility.
Highlights myocardial steatosis as a novel mechanism for obesity-specific cardiomyopathy and a potential biomarker and therapeutic target.
McGavock et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: